Verve Therapeutics Inc

NASDAQ:VERV 4:00:00 PM EDT

15.22

-1.47 (-8.81%)

7:59:16 PM EDT: $15.50 +0.28 (+1.84%)

Market Cap (Intraday)	941.08M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.37 Million
Adjusted EPS	-$0.77

See more estimates

10-Day MA	$16.56
50-Day MA	$20.14
200-Day MA	$25.39

See more pivots

Verve Therapeutics Inc Stock, NASDAQ:VERV

201 Brookline Avenue, Suite 601, Boston, Massachusetts 02215

United States of America

Phone: +1.617.603.0070

Number of Employees: 204

http://www.vervetx.com

Description

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular disease. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, Burt A. Adelman, and Barry Ticho in 2018 and is headquartered in Boston, MA.